Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Central Nervous System Involvement in Peripheral T-Cell Lymphoma

Sangeetha Gandhi, MBBS, N. Nora Bennani, MD, Sonia Fortin, Thomas M. Habermann, MD, Patrick Johnston, MD, James R. Cerhan, MD PhD, Kay M. Ristow, BS, Carrie A. Thompson, MD, Grzegorz Nowakowski, MD, Yi Lin, MD PhD, Jose C Villasboas, MD, Luis Porrata, MD, Thomas E. Witzig, MD, Ivana Micallef, MD, David J Inwards, MD, Stephen M Ansell, MD PhD, Jonas Paludo, MD

Blood (2019) 134 (Supplement_1): 5293.

https://doi.org/10.1182/blood-2019-131965

Published: 2019

Journal Articles

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Sarah Bryant, BS, Ian Moore, PhD, Bianca Nagata, Danielle Springer, VMD, DACLAM, Audrey Noguchi, Morteza Peiravi, Karlie Sharma, PhD, Sherry M. Koontz, Harry Malech, MD, Elizabeth Kang, MD

Blood (2017) 130 (Supplement 1): 3172.

https://doi.org/10.1182/blood.V130.Suppl_1.3172.3172

Published: 2017

Journal Articles

Acute Common Iliac Artery Thrombosis with Concurrent Pulmonary Embolism Revealing AML M2: Role of Elevated Plasma Tissue Factor Activity

Hind Bennani, PharmD, Raphaël Coscas, MD, Marc Coggia, MD, Patrick Van Dreden, PhD, Marc Vasse, PharmD, Jacques Vargaftig, MD

Blood (2015) 126 (23): 4722.

https://doi.org/10.1182/blood.V126.23.4722.4722

Published: 2015

Journal Articles

Clinical Features and Outcome of Patients with Acute Myeloid Leukaemia (AML) and Central Nervous System Involvement at the Time of Diagnosis and during the Course of AML - Retrospective, Multicentre Study of the Polish Adult Leukemia Group (PALG)

Elzbieta Patkowska, MD, Joanna Gora Tybor, MDPhD, Ewa Lech Maranda, MDPhD, Maciej Kazmierczak, MDPhD, Marta Baranska, MD PhD, Andrzej Szczepaniak, MD, Monika Paluszewska, MD PhD, Wieslaw W Jedrzejczak, MDPhD, Renata Guzicka Kazmierczak, MD PhD, Wanda Knopinska Posluszny, MD PhD, Olga Grzybowska Izydorczyk, MD PhD, Jaroslaw Piszcz, MD PhD, Izabela Deren Wagemann, MD PhD, Krzysztof Warzocha, MD PhD

Blood (2015) 126 (23): 1321.

https://doi.org/10.1182/blood.V126.23.1321.1321

Published: 2015

Journal Articles

Promising Results of Ibrutinib in Three Patients with Secondary Central Nervous System Mantle Cell Lymphoma

Sophie Bernard, Lauriane Goldwirt, Sandy Amorim, MD, Pauline Brice, MD, Josette Briere, MD, Helene Sauvageon, Catherine Thieblemont, MD PhD

Blood (2014) 124 (21): 3105.

https://doi.org/10.1182/blood.V124.21.3105.3105

Published: 2014

Journal Articles

What Is The Optimal Dose Of Methotrexate In Primary Central Nervous System Lymphoma Treatment Regimens?

Samir Dalia, MD, Samantha L Price, PharmD, Peter Forsyth, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Michael V. Jaglal, MD

Blood (2013) 122 (21): 3040.

https://doi.org/10.1182/blood.V122.21.3040.3040

Published: 2013

Journal Articles

Spinal Artery Thrombosis: An Unrecognized Severe Complication in Thalassemia and Sickle Disorders

Maria Marzolini, Erika Poggiali, MD, Mohsin Badat, Elena Cassinerio, MD, Maria D Cappellini, John B. Porter, MD

Blood (2012) 120 (21): 1155.

https://doi.org/10.1182/blood.V120.21.1155.1155

Published: 2012

Journal Articles

Continuous Dose Dasatinib Is Safe and Feasible in Combination with Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph + ALL): Children's Oncology Group (COG) Trial AALL0622

Blood (2012) 120 (21): 137.

https://doi.org/10.1182/blood.V120.21.137.137

Published: 2012

Journal Articles

Primary CNS Lymphoma in a HIV Negative Population: A Review of Clinicopathologic Characteristics, Therapy, and Outcomes of 59 Patients

Michael V. Jaglal, MD, Bijal D. Shah, MD, Jennifer L. Cultrera, MD, Eduardo M. Sotomayor, MD, Michael B Tomblyn, MD, MS, Celeste M. Bello, MD, Lubomir Sokol, MD, PhD

Blood (2012) 120 (21): 4858.

https://doi.org/10.1182/blood.V120.21.4858.4858

Published: 2012

Journal Articles

Factor XIII Deficiency Improves Motor Function in Mice Challenged with Experimental Autoimmune Encephalomyelitis, An Established Model of Multiple Sclerosis

Eric S. Mullins, MD, Kathryn E. Talmage, Keith W. Kombrinck, Whitney M Miller, Joseph S. Palumbo, MD, Jay L. Degen, PhD

Blood (2011) 118 (21): 858.

https://doi.org/10.1182/blood.V118.21.858.858

Published: 2011

Journal Articles

EDA-Containing Fibronectin Aggravates Ischemic Brain Injury In Mice

Anil Chauhan, PhD, Mohammad M Khan, Ph.D, Chintan Gandhi, Ph.D, Neelam Chauhan, Ph.D, Asgar Zaheer, Ph.D, David G Motto, MD, PhD, Steven R. Lentz

Blood (2010) 116 (21): 330.

https://doi.org/10.1182/blood.V116.21.330.330

Published: 2010

Journal Articles

Recombinant ADAMTS13 Improves Neurological Outcome in Experimental Stroke in Mice.

Anil K. Chauhan, PhD, Bing-Qiao Zhao, Ph.D, Matthias Canault, PhD, Ian Sean Patten, BS, Janie Yang, BS, Michael Dockal, PhD, Friedrich Scheiflinger, PhD, Denisa D. Wagner, PhD

Blood (2009) 114 (22): 3134.

https://doi.org/10.1182/blood.V114.22.3134.3134

Published: 2009

Journal Articles

Is Differential Activity of Enoxaparin and Unfractionated Heparin According to the Location of Deep-Vein Thrombosis in Acute Ischemic Stroke Patients Driven by Different Pathogenic Mechanisms?.

Ludovic Drouet, David G. Sherman, Gregory W. Albers, Christopher Bladin, Cesare Fieschi, Alberto A. Gabbai, Carlos S. Kase, William O’Riordan, Graham F. Pineo

Blood (2007) 110 (11): 303.

https://doi.org/10.1182/blood.V110.11.303.303

Published: 2007

Journal Articles

Peripheral Neuropathy (PN) in Multiple Myeloma (MM) Responder Patients during Maintenance Therapy with Low-Intermittent Doses of Thalidomide (TAL).

Michele Bibas, MD, Teresa Mignogna, MD, Carla Gualandi, MD, Claudio Geraldini, MD, Nicoletta Villivà, MD, Daniela Tarquini, MD, Alessandro Andriani, MD

Blood (2007) 110 (11): 4829.

https://doi.org/10.1182/blood.V110.11.4829.4829

Published: 2007

Journal Articles

Prevention of Venous Thromboembolism after Acute Ischemic Stroke with Enoxaparin Versus Unfractionated Heparin and the Impact of Stroke Severity.

David G. Sherman, MD, Gregory W. Albers, MD, Christopher Bladin, MD, Min Chen, MS, Cesare Fieschi, MD, Alberto A. Gabbai, MD, Carlos S. Kase, MD, William O’Riordan, MD, Graham F. Pineo, MD, for the PREVAIL Investigators

Blood (2006) 108 (11): 713.

https://doi.org/10.1182/blood.V108.11.713.713

Published: 2006

Journal Articles

Cataracts and Other Neurosensory and Neuromotor Late Effects in Childhood HSCT Survivors.

James G. Gurney, PhD, Kirsten K. Ness, PhD, Joseph Rosenthal, MD, Stephen J. Forman, MD, Smita Bhatia, MD, K. Scott Baker, MD

Blood (2005) 106 (11): 1110.

https://doi.org/10.1182/blood.V106.11.1110.1110

Published: 2005

Journal Articles

Increased Red Cell Adhesion Is Associated with Overt Stroke in Sickle Cell Disease.

Kimberly M. Rennie, PhD, J. Paul Scott, MD, Julie A. Panepinto, MD, Cheryl A. Hillery, MD

Blood (2005) 106 (11): 2320.

https://doi.org/10.1182/blood.V106.11.2320.2320

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Central Nervous System Involvement in Peripheral T-Cell Lymphoma

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Acute Common Iliac Artery Thrombosis with Concurrent Pulmonary Embolism Revealing AML M2: Role of Elevated Plasma Tissue Factor Activity

Clinical Features and Outcome of Patients with Acute Myeloid Leukaemia (AML) and Central Nervous System Involvement at the Time of Diagnosis and during the Course of AML - Retrospective, Multicentre Study of the Polish Adult Leukemia Group (PALG)

Promising Results of Ibrutinib in Three Patients with Secondary Central Nervous System Mantle Cell Lymphoma

What Is The Optimal Dose Of Methotrexate In Primary Central Nervous System Lymphoma Treatment Regimens?

Spinal Artery Thrombosis: An Unrecognized Severe Complication in Thalassemia and Sickle Disorders

Continuous Dose Dasatinib Is Safe and Feasible in Combination with Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph + ALL): Children's Oncology Group (COG) Trial AALL0622

Primary CNS Lymphoma in a HIV Negative Population: A Review of Clinicopathologic Characteristics, Therapy, and Outcomes of 59 Patients

Factor XIII Deficiency Improves Motor Function in Mice Challenged with Experimental Autoimmune Encephalomyelitis, An Established Model of Multiple Sclerosis

EDA-Containing Fibronectin Aggravates Ischemic Brain Injury In Mice

Recombinant ADAMTS13 Improves Neurological Outcome in Experimental Stroke in Mice.

Is Differential Activity of Enoxaparin and Unfractionated Heparin According to the Location of Deep-Vein Thrombosis in Acute Ischemic Stroke Patients Driven by Different Pathogenic Mechanisms?.

Peripheral Neuropathy (PN) in Multiple Myeloma (MM) Responder Patients during Maintenance Therapy with Low-Intermittent Doses of Thalidomide (TAL).

Prevention of Venous Thromboembolism after Acute Ischemic Stroke with Enoxaparin Versus Unfractionated Heparin and the Impact of Stroke Severity.

Cataracts and Other Neurosensory and Neuromotor Late Effects in Childhood HSCT Survivors.

Increased Red Cell Adhesion Is Associated with Overt Stroke in Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only